Table 3.
Patient characteristics according to IHC marker expression
| Variable | p63 (n = 73) | P* | p40 (n = 74) | P* | CK5/6 (n = 68) | P* | |||
|---|---|---|---|---|---|---|---|---|---|
| H >150 n (%) (n = 58) | H ≤150 n (%) (n = 15) | H >150 n (%) (n = 30) | H ≤150 n (%) (n = 44) | H >150 n (%) (n = 41) | H ≤150 n (%) (n = 27) | ||||
| Age† | |||||||||
| ≤61 y | 25 (43.1) | 9 (60.0) | 0.242 | 15 (50.0) | 18 (40.9) | 0.440 | 15 (36.6) | 14 (51.9) | 0.213 |
| >61 y | 33 (56.9) | 6 (40.0) | 15 (50.0) | 26 (59.1) | 26 (63.4) | 13 (48.1) | |||
| Gender | |||||||||
| Male | 57 (98.3) | 12 (80.0) | 0.033 | 29 (96.7) | 40 (90.9) | 0.619 | 41 (100.0) | 22 (81.5) | 0.008 |
| Female | 1 (1.7) | 3 (20.0) | 1 (3.3) | 4 (9.1) | 0 (0.0) | 5 (18.5) | |||
| Smoking history | |||||||||
| Ever | 46 (79.3) | 9 (60.0) | 0.226 | 23 (76.7) | 32 (72.7) | 0.703 | 32 (78.0) | 17 (63.0) | 0.175 |
| Never | 12 (20.7) | 6 (40.0) | 7 (23.3) | 12 (27.3) | 9 (22.0) | 10 (37.0) | |||
| pT stage | |||||||||
| pT1 | 24 (41.4) | 6 (40.0) | 0.923 | 13 (43.3) | 18 (40.9) | 0.836 | 15 (36.6) | 15 (55.6) | 0.123 |
| pT2–4 | 34 (58.6) | 9 (60.0) | 17 (56.7) | 26 (59.1) | 26 (63.4) | 12 (44.4) | |||
| Histological grade | |||||||||
| Well, moderately | 31 (53.4) | 5 (33.3) | 0.165 | 18 (40.9) | 18 (60.0) | 0.107 | 20 (48.8) | 12 (44.4) | 0.726 |
| Poorly | 27 (46.6) | 10 (66.7) | 12 (59.1) | 26 (40.0) | 21 (51.2) | 15 (55.6) | |||
*Statistical significance was calculated by the χ2 test or Fisher's exact test. †The median age of the entire population is indicated. H, histologic scores; IHC, immunohistochemistry.